Literature DB >> 22622448

Community-associated meticillin-resistant Staphylococcus aureus: the case for a genotypic definition.

J A Otter1, G L French.   

Abstract

BACKGROUND: New distinct strains of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA) have emerged as a cause of infection in previously healthy individuals in community settings. It is important to identify CA-MRSA for clinical management, epidemiological analysis, infection prevention and control, and regulatory reporting, but definitions and nomenclature of these strains are confused. AIM: To review attempts to define CA-MRSA and propose a new definition.
METHODS: Non-systematic review.
FINDINGS: Epidemiological definitions were useful for differentiating CA-MRSA and healthcare-associated (HA)-MRSA strain types in the past. However, although HA-MRSA strain types are rarely transmitted in the community, CA-MRSA strains have started to be transmitted in healthcare facilities, so epidemiological definitions are breaking down. CA-MRSA are community strains of S. aureus that have acquired the meticillin resistance gene, mecA. They are distinct from HA-MRSA and should be defined genetically. This may be done by combining genotypic typing by multi-locus sequence or spa with analysis of the staphylococcal cassette chromosome mec. Carriage of Panton-Valentine leukocidin or antimicrobial susceptibility profiles can be useful indicators of CA-MRSA but should not be used for their definition.
CONCLUSION: For full assessment of their epidemiology, MRSA infections should be characterized as: (1) caused by HA- or CA-MRSA strain types; (2) acquired in community or healthcare settings; and (3) onset in the community or healthcare facility.
Copyright © 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22622448     DOI: 10.1016/j.jhin.2012.04.009

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  31 in total

1.  Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 3: Current Perspectives on Skin and Soft Tissue Infections with Emphasis on Methicillin-resistant Staphylococcus aureus, Commonly Encountered Scenarios when Antibiotic Use May Not Be Needed, and Concluding Remarks on Rational Use of Antibiotics in Dermatology.

Authors:  James Q Del Rosso; Ted Rosen; Diane Thiboutot; Guy F Webster; Richard L Gallo; James J Leyden; Clay Walker; George Zhanel; Lawrence Eichenfield
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

2.  Antibiotic Resistance Trends in Methicillin-Resistant Staphylococcus aureus Isolated in Kuwait Hospitals: 2011-2015.

Authors:  Edet E Udo; Samar S Boswihi
Journal:  Med Princ Pract       Date:  2017-10-04       Impact factor: 1.927

Review 3.  Resistant pathogens, fungi, and viruses.

Authors:  Christopher A Guidry; Sara A Mansfield; Robert G Sawyer; Charles H Cook
Journal:  Surg Clin North Am       Date:  2014-10-03       Impact factor: 2.741

4.  rRNA Operon Copy Number Can Explain the Distinct Epidemiology of Hospital-Associated Methicillin-Resistant Staphylococcus aureus.

Authors:  A C Fluit; M D Jansen; T Bosch; W T M Jansen; L Schouls; M J Jonker; C H E Boel
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 5.  Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology.

Authors:  Sahreena Lakhundi; Kunyan Zhang
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

6.  Dissemination of methicillin-resistant Staphylococcus aureus SCCmec type IV and SCCmec type V epidemic clones in a tertiary hospital: challenge to infection control.

Authors:  B Dhawan; C Rao; E E Udo; R Gadepalli; S Vishnubhatla; A Kapil
Journal:  Epidemiol Infect       Date:  2014-04-02       Impact factor: 4.434

Review 7.  Methicillin Resistant Staphylococcus aureus and public fomites: a review.

Authors:  Ziad W Jaradat; Qutaiba O Ababneh; Sherin T Sha'aban; Ayesha A Alkofahi; Duaa Assaleh; Anan Al Shara
Journal:  Pathog Glob Health       Date:  2020-10-28       Impact factor: 2.894

8.  Clinical characteristics, virulence factors and molecular typing of methicillin-resistant Staphylococcus aureus infections in Shenzhen City, China.

Authors:  L Hu; Y Li; Y Lu; J D Klena; Y Qiu; Y Lin; M Jiang; X Shi; L Chen; X Liu; H Ma; J Cheng; S Wu; B Kan; Q Hu
Journal:  Epidemiol Infect       Date:  2016-07-22       Impact factor: 4.434

9.  Comparing the epidemiology of hospital-acquired methicillin-resistant Staphylococcus aureus clone groups in Alberta, Canada.

Authors:  S Bruzzese; K Bush; J Leal; J Kim; D M Vickers; A Rusk; S Fathima; V Li; L Chui; M Louie; E Henderson
Journal:  Epidemiol Infect       Date:  2016-03-07       Impact factor: 4.434

10.  Detection of methicillin-resistant Staphylococcus aureus carrying the mecC gene in human samples in Slovenia.

Authors:  U Dermota; I Zdovc; I Strumbelj; I Grmek-Kosnik; H Ribic; M Rupnik; M Golob; U Zajc; M Bes; F Laurent; M Mueller-Premru
Journal:  Epidemiol Infect       Date:  2014-07-18       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.